The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer

BACKGROUND: This study was conducted to propose the optimal duration of fluoropyrimidine-based adjuvant chemotherapy consisting of fluoropyrimidine derivatives alone or combined with intravenous platinum for stage II or III gastric cancer (GC). METHODS: We analyzed retrospectively the data from 2219...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seong-Geun, Hwang, Sun-Hwi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818924/
https://www.ncbi.nlm.nih.gov/pubmed/27039375
http://dx.doi.org/10.1186/s12957-016-0845-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818924/
https://www.ncbi.nlm.nih.gov/pubmed/27039375
http://dx.doi.org/10.1186/s12957-016-0845-1

Ejemplares similares